- Home
- USLM vs HCM Comparison
USLM vs HCM Comparison
Compare USLM & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USLM
- HCM
- Stock Information
- Founded
- USLM 1948
- HCM 2000
- Country
- USLM United States
- HCM Hong Kong
- Employees
- USLM N/A
- HCM N/A
- Industry
- USLM Other Metals and Minerals
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- USLM Industrials
- HCM Health Care
- Exchange
- USLM Nasdaq
- HCM Nasdaq
- Market Cap
- USLM 2.5B
- HCM 2.5B
- IPO Year
- USLM N/A
- HCM N/A
- Fundamental
- Price
- USLM $98.99
- HCM $14.21
- Analyst Decision
- USLM
- HCM Hold
- Analyst Count
- USLM 0
- HCM 1
- Target Price
- USLM N/A
- HCM $19.00
- AVG Volume (30 Days)
- USLM 79.4K
- HCM 82.7K
- Earning Date
- USLM 04-30-2025
- HCM 03-19-2025
- Dividend Yield
- USLM 0.24%
- HCM N/A
- EPS Growth
- USLM 50.52
- HCM N/A
- EPS
- USLM 4.20
- HCM 0.04
- Revenue
- USLM $337,287,000.00
- HCM $630,201,000.00
- Revenue This Year
- USLM N/A
- HCM $14.86
- Revenue Next Year
- USLM N/A
- HCM $19.54
- P/E Ratio
- USLM $23.46
- HCM $68.70
- Revenue Growth
- USLM 17.83
- HCM N/A
- 52 Week Low
- USLM $64.25
- HCM $11.51
- 52 Week High
- USLM $159.53
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- USLM 59.34
- HCM 45.83
- Support Level
- USLM $96.51
- HCM $14.18
- Resistance Level
- USLM $100.75
- HCM $14.84
- Average True Range (ATR)
- USLM 3.50
- HCM 0.57
- MACD
- USLM 0.78
- HCM -0.03
- Stochastic Oscillator
- USLM 81.40
- HCM 1.94
About USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.